Despite earlier observational studies, bisphosphonate treatment for 3 to 4 years appears not to decrease the risk of invasive postmenopausal breast cancer, according to a new study in JAMA Internal Medicine.
A prospective Italian study published in The Journal of Clinical Endocrinology & Metabolism suggests that low levels of vitamin D [25(OH)D] may contribute to infertility. The finding, which the authors acknowledge does not confirm causality, could point to possible therapeutic benefits of the vitamin in women undergoing in vitro fertilization (IVF).
According to a new study in Cancer Epidemiology Biomarkers & Prevention, brisk walking or vigorous exercise may help reduce risk of breast cancer in African-American women.
Avastin (bevacizumab) has been approved to treat patients with persistent, recurrent, or metastatic cervical cancer by the US Food and Drug Administration (FDA).
Mutations in the PALB2 gene may be associated with a significant increase in the risk of breast cancer, according to a recent study in The New England Journal of Medicine. PALB2 binds to BRCA2—a gene that confers increased lifetime risk of developing breast or ovarian cancer—and likely permits its stable nuclear localization and accumulation.